AbbVie Inc.
ABBV
$225.11
-$2.59-1.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.40% | 6.05% | 5.45% | 3.71% | 0.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.40% | 6.05% | 5.45% | 3.71% | 0.72% |
| Cost of Revenue | 3.29% | 0.83% | -0.06% | 0.85% | -0.16% |
| Gross Profit | 9.16% | 8.35% | 7.91% | 4.99% | 1.09% |
| SG&A Expenses | -9.05% | 0.95% | 3.20% | 3.01% | 12.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -118.34% | -118.34% | -- | 30.00% | 193.89% |
| Total Operating Expenses | 0.30% | 3.27% | 4.31% | 4.44% | 7.52% |
| Operating Income | 23.52% | 12.05% | 7.88% | 2.21% | -11.93% |
| Income Before Tax | -76.93% | -57.12% | -51.90% | -40.54% | -10.07% |
| Income Tax Expenses | -135.61% | -143.18% | -138.07% | -141.39% | 39.27% |
| Earnings from Continuing Operations | -53.34% | -29.51% | -30.00% | -12.05% | -21.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.36% | 27.27% | 27.27% | 20.00% | -57.14% |
| Net Income | -53.38% | -29.52% | -30.00% | -12.03% | -21.37% |
| EBIT | 23.52% | 12.05% | 7.88% | 2.21% | -11.93% |
| EBITDA | 15.34% | 7.15% | 4.13% | 0.30% | -9.69% |
| EPS Basic | -53.76% | -29.71% | -30.18% | -12.09% | -21.38% |
| Normalized Basic EPS | 21.79% | 9.43% | 5.71% | 0.90% | -12.62% |
| EPS Diluted | -54.01% | -29.95% | -30.25% | -12.11% | -21.38% |
| Normalized Diluted EPS | 21.78% | 9.45% | 5.75% | 0.97% | -12.58% |
| Average Basic Shares Outstanding | -0.06% | -0.03% | -0.01% | -0.01% | -0.06% |
| Average Diluted Shares Outstanding | -0.06% | -0.04% | -0.04% | -0.07% | -0.11% |
| Dividend Per Share | 5.81% | 5.55% | 5.28% | 5.01% | 4.73% |
| Payout Ratio | 1.26% | 0.49% | 0.50% | 0.19% | 0.33% |